Mesoblast appoints James M. O'Brien as US-based CFO
Source: SeekingAlpha
2025-11-17 02:32:41 ET
Mesoblast ( MESO ) has named James M. O’Brien as its US-based Chief Financial Officer, effective immediately....
Read the full article on Seeking Alpha
For further details see:
Mesoblast appoints James M. O’Brien as US-based CFO
Mesoblast Ltd Ord
NASDAQ: MEOBF
MEOBF Trading
0.0% G/L:
$1.55 Last:
2,000 Volume:
$1.55 Open:
MEOBF Latest News
March 11, 2026 07:21:39 pm
Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast
MEOBF Stock Data
$2,165,966,075
573,072,937
N/A
91
N/A
Biotechnology & Life Sciences
Healthcare
AU
Melbourne
